4,160
Views
482
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation

, , , , , , , & show all
Pages 306-321 | Published online: 08 Jul 2009

Figures & data

Figure 1. Effects of 6‐month regimen of low‐dose doxycycline (LDD; B = before, A = after) or placebo on plasma levels of pro‐inflammatory biomarkers in patients (n = 30) with acute coronary syndromes (ACS). (a): MMP‐8; (b): MMP‐9; (c): C‐reactive protein (CRP). MMP‐8 and ‐9 values represent densitometric scanning units and CRP represent µg/mL, and are expressed as means + SDs. (MMP = matrix metalloproteinases.)

Figure 1. Effects of 6‐month regimen of low‐dose doxycycline (LDD; B = before, A = after) or placebo on plasma levels of pro‐inflammatory biomarkers in patients (n = 30) with acute coronary syndromes (ACS). (a): MMP‐8; (b): MMP‐9; (c): C‐reactive protein (CRP). MMP‐8 and ‐9 values represent densitometric scanning units and CRP represent µg/mL, and are expressed as means + SDs. (MMP = matrix metalloproteinases.)

Figure 2. Test positive result of the MMP‐8 specific chair‐side dip‐stick is confirmed with the appearance of the blue line in the catching zone (left, indicated by arrows). (MMP = matrix metalloproteinases.)

Figure 2. Test positive result of the MMP‐8 specific chair‐side dip‐stick is confirmed with the appearance of the blue line in the catching zone (left, indicated by arrows). (MMP = matrix metalloproteinases.)

Figure 3. Scattergram of periodontitis patients' sites (n = 133) at baseline; correlation of MMP‐8 concentration (assessed by IFMA, µg/L) and MMP‐8 specific chair‐side dipstick test results (0 = negative; 1 = +; 2 = ++; 3 = +++). (IFMA = time‐resolved immunofluorometric assay; MMP = matrix metalloproteinases.)

Figure 3. Scattergram of periodontitis patients' sites (n = 133) at baseline; correlation of MMP‐8 concentration (assessed by IFMA, µg/L) and MMP‐8 specific chair‐side dipstick test results (0 = negative; 1 = +; 2 = ++; 3 = +++). (IFMA = time‐resolved immunofluorometric assay; MMP = matrix metalloproteinases.)

Figure 4. MMP‐8 concentration in GCF (µg/L, bars) collected from 5–8 distinct sites from periodontitis patients (n = 8) and assessed by IFMA and MMP‐8 specific chair‐side dipstick test (−; +; ++ and +++) precede loss of attachment (AL, mm) during maintenance phase of periodontal treatment (scaling and root planing). MMP‐8 concentrations and AL are represented as means. (GCF = gingival crevicular fluid; IFMA = time‐resolved immunofluorometric assay; MMP = matrix metalloproteinases.)

Figure 4. MMP‐8 concentration in GCF (µg/L, bars) collected from 5–8 distinct sites from periodontitis patients (n = 8) and assessed by IFMA and MMP‐8 specific chair‐side dipstick test (−; +; ++ and +++) precede loss of attachment (AL, mm) during maintenance phase of periodontal treatment (scaling and root planing). MMP‐8 concentrations and AL are represented as means. (GCF = gingival crevicular fluid; IFMA = time‐resolved immunofluorometric assay; MMP = matrix metalloproteinases.)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.